Speaker: 

Natalie Schmitz, MPA, PHarmD, PhD, Assistant Professor - Pharmacy Practice Division, UW-Madison School of Pharmacy 

Learning Objectives: 

  1. Describe the endocannabinoid system and major cannabinoid compounds
  2. Explain legal status of cannabinoids
  3. Discuss potential therapeutic applications, adverse effects, and drug-drug interactions
  4. Identify the impact of different formulations and routes of administration
  5. Identify important considerations for cannabinoid product selection
  6.  

Credit Designation Statement

American Board of Pediatrics

Successful completion of this CME activity, which included participation in the activity, with individual assessment of the participant and feedback to the participant, enables the participant to earn 1.0 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

Session date: 
Thursday, December 12, 2019 - 7:30am to 8:30am
Location: 
Health Sciences Learning Center
750 Highland Avenue
Room 1345
Madison, WI 53792
United States
Presenter(s): 
Natalie Schmitz, MPA, PharmD, PhD
  • 1.00 MOC: ABP Lifelong Learning Points (Part II)
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Please login or register to take this course.
Discloser List CME Internal Report